Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

Clinical trial NCT00104923 · COMPLETED

Trial details

NCT number: NCT00104923
Sponsor: California Cancer Consortium
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm

Start date: 2005-02-01
Primary completion: 2017-04-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.